HIGH‐RISK PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA ARE NOT ENROLLED ON CLINICAL TRIALS
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2438_42
Abstract: taneous occurrence of DLBCL and FL (DLBCL/FL) in the same lymph node (LN). These pts are treated as DLBCL. The outcome of these pts was not described yet, and these pts are usually excluded from… read more here.
Keywords: outcome; dlbcl; high risk; year ... See more keywords